A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT01646151 · clinicaltrials.gov ↗

COMPLETED

Status

2580

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Bimatoprost

Sponsor

Allergan